23andMe Holding Co.
MEHCQ
$1.15
-$0.02-1.71%
| Weiss Ratings | MEHCQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Very Weak | |||
| Risk Grade | E+ | |||
| Reward Grade | E | |||
| Rating Factors | MEHCQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Fair | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Good | |||
| Total Return Index | Very Weak | |||
| Volatility Index | Very Weak | |||
| Beta / Standard Deviation | MEHCQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.92 | |||
| Price History | MEHCQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -7.26% | |||
| 30-Day Total Return | -47.73% | |||
| 60-Day Total Return | -66.28% | |||
| 90-Day Total Return | -67.61% | |||
| Year to Date Total Return | -67.61% | |||
| 1-Year Total Return | -87.54% | |||
| 2-Year Total Return | -97.37% | |||
| 3-Year Total Return | -98.27% | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | -90.83% | |||
| 52-Week Low % Change | 143.75% | |||
| Price | MEHCQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $12.76 | |||
| 52-Week Low Price | $0.48 | |||
| 52-Week Low Price (Date) | Mar 31, 2025 | |||
| 52-Week High Price (Date) | May 15, 2024 | |||
| Valuation | MEHCQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 31.39M | |||
| Enterprise Value | 12.58M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -15.72 | |||
| Earnings Per Share Growth | -28.76% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 0.15 | |||
| Price/Book (Q) | 0.50 | |||
| Enterprise Value/Revenue (TTM) | 0.06 | |||
| Price | $1.15 | |||
| Enterprise Value/EBITDA (TTM) | -0.08 | |||
| Enterprise Value/EBIT | -0.07 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | MEHCQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 26.35M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | MEHCQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 650 938 6300 | |||
| Address | 349 Oyster Point Boulevard South San Francisco, CA 94080 | |||
| Website | www.23andme.com | |||
| Country | United States | |||
| Year Founded | 2006 | |||
| Profitability | MEHCQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -87.28% | |||
| Profit Margin | -186.98% | |||
| Management Effectiveness | MEHCQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -25.72% | |||
| Return on Equity | -- | |||
| Income Statement | MEHCQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 208.78M | |||
| Total Revenue (TTM) | 208.78M | |||
| Revenue Per Share | $7.92 | |||
| Gross Profit (TTM) | 109.78M | |||
| EBITDA (TTM) | -166.80M | |||
| EBIT (TTM) | -182.23M | |||
| Net Income (TTM) | -390.37M | |||
| Net Income Avl. to Common (TTM) | -390.37M | |||
| Total Revenue Growth (Q YOY) | 34.67% | |||
| Earnings Growth (Q YOY) | 86.80% | |||
| EPS Diluted (TTM) | -15.72 | |||
| EPS Diluted Growth (Q YOY) | 82.59% | |||
| Balance Sheet | MEHCQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 79.35M | |||
| Cash Per Share (Q) | $3.01 | |||
| Total Current Assets (Q) | 161.58M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 62.72M | |||
| Current Ratio (Q) | 1.054 | |||
| Book Value Per Share (Q) | $2.35 | |||
| Total Assets (Q) | 277.42M | |||
| Total Current Liabilities (Q) | 153.34M | |||
| Total Debt (Q) | 60.54M | |||
| Total Liabilities (Q) | 214.70M | |||
| Total Common Equity (Q) | 62.72M | |||
| Cash Flow | MEHCQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -5.12M | |||
| Cash from Financing (TTM) | 2.25M | |||
| Net Change in Cash (TTM) | -157.50M | |||
| Levered Free Cash Flow (TTM) | 21.50K | |||
| Cash from Operations (TTM) | -154.64M | |||
